Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9B1V6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 130 | 134 | PF00656 | 0.481 |
CLV_NRD_NRD_1 | 226 | 228 | PF00675 | 0.520 |
CLV_NRD_NRD_1 | 319 | 321 | PF00675 | 0.584 |
CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.467 |
CLV_PCSK_SKI1_1 | 260 | 264 | PF00082 | 0.365 |
CLV_PCSK_SKI1_1 | 77 | 81 | PF00082 | 0.496 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.353 |
DEG_SPOP_SBC_1 | 239 | 243 | PF00917 | 0.472 |
DOC_CKS1_1 | 101 | 106 | PF01111 | 0.430 |
DOC_CKS1_1 | 58 | 63 | PF01111 | 0.470 |
DOC_CYCLIN_yCln2_LP_2 | 67 | 73 | PF00134 | 0.459 |
DOC_MAPK_gen_1 | 41 | 48 | PF00069 | 0.543 |
DOC_MAPK_MEF2A_6 | 41 | 48 | PF00069 | 0.558 |
DOC_PP2B_LxvP_1 | 44 | 47 | PF13499 | 0.541 |
DOC_USP7_MATH_1 | 106 | 110 | PF00917 | 0.631 |
DOC_USP7_MATH_1 | 291 | 295 | PF00917 | 0.512 |
DOC_USP7_MATH_1 | 71 | 75 | PF00917 | 0.651 |
DOC_WW_Pin1_4 | 100 | 105 | PF00397 | 0.642 |
DOC_WW_Pin1_4 | 57 | 62 | PF00397 | 0.563 |
DOC_WW_Pin1_4 | 66 | 71 | PF00397 | 0.744 |
LIG_14-3-3_CanoR_1 | 148 | 155 | PF00244 | 0.380 |
LIG_14-3-3_CanoR_1 | 214 | 222 | PF00244 | 0.517 |
LIG_14-3-3_CanoR_1 | 268 | 274 | PF00244 | 0.487 |
LIG_14-3-3_CanoR_1 | 309 | 315 | PF00244 | 0.451 |
LIG_14-3-3_CanoR_1 | 41 | 47 | PF00244 | 0.633 |
LIG_14-3-3_CanoR_1 | 5 | 11 | PF00244 | 0.463 |
LIG_14-3-3_CanoR_1 | 72 | 81 | PF00244 | 0.498 |
LIG_Actin_WH2_2 | 307 | 322 | PF00022 | 0.554 |
LIG_BRCT_BRCA1_1 | 108 | 112 | PF00533 | 0.502 |
LIG_CSL_BTD_1 | 11 | 14 | PF09270 | 0.334 |
LIG_eIF4E_1 | 82 | 88 | PF01652 | 0.489 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.479 |
LIG_FHA_1 | 182 | 188 | PF00498 | 0.314 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.572 |
LIG_FHA_1 | 29 | 35 | PF00498 | 0.379 |
LIG_FHA_1 | 58 | 64 | PF00498 | 0.614 |
LIG_LIR_Nem_3 | 109 | 115 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 183 | 188 | PF02991 | 0.337 |
LIG_PCNA_yPIPBox_3 | 226 | 237 | PF02747 | 0.479 |
LIG_SH2_CRK | 212 | 216 | PF00017 | 0.393 |
LIG_SH2_SRC | 118 | 121 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.377 |
LIG_SH2_STAT5 | 212 | 215 | PF00017 | 0.490 |
LIG_SH3_3 | 1 | 7 | PF00018 | 0.301 |
LIG_SH3_3 | 252 | 258 | PF00018 | 0.444 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.281 |
LIG_SH3_3 | 88 | 94 | PF00018 | 0.471 |
LIG_SUMO_SIM_anti_2 | 19 | 24 | PF11976 | 0.331 |
LIG_SUMO_SIM_par_1 | 135 | 141 | PF11976 | 0.395 |
LIG_SUMO_SIM_par_1 | 153 | 159 | PF11976 | 0.494 |
LIG_SUMO_SIM_par_1 | 234 | 246 | PF11976 | 0.517 |
LIG_SUMO_SIM_par_1 | 30 | 35 | PF11976 | 0.394 |
LIG_TRAF2_1 | 276 | 279 | PF00917 | 0.590 |
MOD_CDC14_SPxK_1 | 69 | 72 | PF00782 | 0.460 |
MOD_CDK_SPxK_1 | 66 | 72 | PF00069 | 0.462 |
MOD_CK1_1 | 122 | 128 | PF00069 | 0.498 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.549 |
MOD_CK1_1 | 242 | 248 | PF00069 | 0.616 |
MOD_CK1_1 | 294 | 300 | PF00069 | 0.574 |
MOD_CK2_1 | 111 | 117 | PF00069 | 0.550 |
MOD_CK2_1 | 166 | 172 | PF00069 | 0.607 |
MOD_CK2_1 | 273 | 279 | PF00069 | 0.577 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.570 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.510 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.523 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.515 |
MOD_GlcNHglycan | 296 | 299 | PF01048 | 0.448 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.515 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.396 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.470 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.536 |
MOD_GSK3_1 | 269 | 276 | PF00069 | 0.561 |
MOD_GSK3_1 | 279 | 286 | PF00069 | 0.572 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.678 |
MOD_N-GLC_1 | 273 | 278 | PF02516 | 0.529 |
MOD_NEK2_1 | 119 | 124 | PF00069 | 0.546 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.370 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.339 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.352 |
MOD_NEK2_1 | 187 | 192 | PF00069 | 0.353 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.364 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.315 |
MOD_NEK2_2 | 36 | 41 | PF00069 | 0.419 |
MOD_PIKK_1 | 245 | 251 | PF00454 | 0.701 |
MOD_PKA_2 | 147 | 153 | PF00069 | 0.381 |
MOD_PKA_2 | 279 | 285 | PF00069 | 0.531 |
MOD_PKA_2 | 294 | 300 | PF00069 | 0.407 |
MOD_PKA_2 | 42 | 48 | PF00069 | 0.621 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.434 |
MOD_Plk_1 | 119 | 125 | PF00069 | 0.491 |
MOD_Plk_1 | 161 | 167 | PF00069 | 0.421 |
MOD_Plk_1 | 273 | 279 | PF00069 | 0.526 |
MOD_Plk_1 | 75 | 81 | PF00069 | 0.657 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.472 |
MOD_Plk_4 | 16 | 22 | PF00069 | 0.272 |
MOD_Plk_4 | 28 | 34 | PF00069 | 0.437 |
MOD_Plk_4 | 6 | 12 | PF00069 | 0.368 |
MOD_ProDKin_1 | 100 | 106 | PF00069 | 0.641 |
MOD_ProDKin_1 | 57 | 63 | PF00069 | 0.575 |
MOD_ProDKin_1 | 66 | 72 | PF00069 | 0.745 |
TRG_DiLeu_BaEn_1 | 76 | 81 | PF01217 | 0.507 |
TRG_DiLeu_BaEn_4 | 196 | 202 | PF01217 | 0.480 |
TRG_DiLeu_BaLyEn_6 | 44 | 49 | PF01217 | 0.534 |
TRG_ENDOCYTIC_2 | 212 | 215 | PF00928 | 0.378 |
TRG_ER_diArg_1 | 226 | 228 | PF00400 | 0.520 |
TRG_ER_diArg_1 | 40 | 43 | PF00400 | 0.607 |
TRG_Pf-PMV_PEXEL_1 | 226 | 230 | PF00026 | 0.448 |
TRG_Pf-PMV_PEXEL_1 | 24 | 28 | PF00026 | 0.375 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6A2 | Leptomonas seymouri | 63% | 99% |
A0A1X0NQ31 | Trypanosomatidae | 39% | 97% |
A0A3R7KN88 | Trypanosoma rangeli | 42% | 100% |
A0A3S7X4K4 | Leishmania donovani | 93% | 100% |
A4HJD7 | Leishmania braziliensis | 86% | 100% |
A4I6T4 | Leishmania infantum | 93% | 100% |
C9ZMA6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
Q4Q6A6 | Leishmania major | 92% | 100% |
V5BFH9 | Trypanosoma cruzi | 41% | 100% |